Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
DSM Nutritional Products LLC holds a company patent portfolio focused on Biotechnology & Pharmaceuticals. There is currently 1 pending office action associated with this portfolio. This action is being handled by 1 distinct examiner and is situated within 1 distinct art unit. This reflects a very specific and limited scope of current prosecution activity. For a practitioner, this means that the prosecution strategy is entirely dependent on the interaction with this 1 distinct examiner and the specific standards of the 1 distinct art unit.
The busiest examiner for DSM Nutritional Products LLC is LAU, JONATHAN S, who has 1 busiest examiner pending action. As the total count of pending office actions is 1, LAU, JONATHAN S is the sole official responsible for the company's current patent review. The involvement of only 1 distinct art unit further suggests that the pending matter falls within a specific technical niche of the Biotechnology & Pharmaceuticals field. This concentration requires a targeted approach to satisfy the examiner's requirements, as the outcome of the 1 pending office action will define the current success of the portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LAU, JONATHAN S | 1 | 63.9% | -17.2% |
| Art Unit | Apps |
|---|---|
| 1693 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18698176 | OLIGOSACCHARIDE COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING INFLAMMATORY LUNG DISEASES | LAU, JONATHAN S | 1693 | §102§103§112DP | Non-Final OA | — | Pending | Apr 03, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialDSM Nutritional Products LLC has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jonathan S Lau has the most, with 1 of DSM Nutritional Products LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
